Three-quarters of FDA regs could be deleted or "reinvented," FDA's Holston says.
This article was originally published in The Tan Sheet
Executive Summary
THREE-QUARTERS OF FDA REGS COULD BE DELETED OR "REINVENTED," FDA Office of External Affairs Deputy Commissioner Sharon Smith Holston told the National Association of Pharmaceutical Manufacturers mid-year meeting in Washington, D.C. June 21. Results of an internal review of regulations "surprised even those of us who suspected that we probably had more regulations on the books than we actually needed to do our job," Holston said.